Loading data
CAGNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 11.28 bn USD | 11.61 bn USD | 12.05 bn USD | 12.28 bn USD | 11.54 bn USD |
| Cost of revenue | 8.58 bn USD | 8.61 bn USD | 8.72 bn USD | 9.01 bn USD | 8.7 bn USD |
| Gross profit | 2.7 bn USD | 3 bn USD | 3.33 bn USD | 3.26 bn USD | — |
| Research and development expense | 62.7 m USD | 60.8 m USD | 61.4 m USD | 57.7 m USD | 53.4 m USD |
| Selling, general and administrative expense | 1.44 bn USD | 1.54 bn USD | 1.49 bn USD | 1.43 bn USD | 1.49 bn USD |
| Operating profit | -1.63 bn USD | 1.36 bn USD | 852.8 m USD | 1.08 bn USD | 1.59 bn USD |
| Profit before tax | -1.82 bn USD | 1.16 bn USD | 610.2 m USD | 901.9 m USD | 1.18 bn USD |
| Income tax expense | 91.8 m USD | 3.7 m USD | 262.5 m USD | 218.7 m USD | 290.5 m USD |
| Net income (reported basis) | -1.92 bn USD | 1.15 bn USD | 347.7 m USD | 683.2 m USD | 888.2 m USD |
| Basic earnings per share | -4 USD/share | 2.41 USD/share | 0.73 USD/share | 1.43 USD/share | 1.85 USD/share |
| Diluted earnings per share | -4 USD/share | 2.4 USD/share | 0.72 USD/share | 1.42 USD/share | 1.84 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.